Related Experiment Video

Updated: Aug 30, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Role of class I and class II histone deacetylases in carcinoma cells using siRNA

Keith B Glaser1, Junling Li, Michael J Staver

  • 1Cancer Research, R47J-AP9, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-6121, USA. keith.glaser@abbott.com

Biochemical and Biophysical Research Communications
|October 3, 2003
PubMed

Insights

Class I histone deacetylases (HDACs), specifically HDAC1 and HDAC3, are crucial for regulating cancer cell proliferation and survival. Targeting these HDACs shows promise for developing new cancer therapeutics.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Histone deacetylases (HDACs) are enzymes involved in gene regulation.
  • Aberrant HDAC activity is linked to various cancers.
  • Understanding individual HDAC roles is critical for targeted cancer therapy.

Purpose of the Study:

  • To investigate the specific roles of individual HDACs in cancer cell proliferation and survival.
  • To determine the effects of targeting Class I HDACs (HDAC1, HDAC3) versus Class II HDACs (HDAC4, HDAC7).

Main Methods:

  • Utilized siRNA-mediated protein knockdown to selectively reduce HDAC expression in HeLa S3 cancer cells.
  • Observed morphological changes and measured cell proliferation rates.
  • Assessed histone acetylation levels and quantified apoptosis.

Main Results:

  • siRNA targeting HDAC1 and HDAC3 induced significant morphological changes and inhibited HeLa S3 cell proliferation in a dose-dependent manner.
  • HDAC1 and HDAC3 knockdown led to histone hyperacetylation and increased apoptosis.
  • siRNA targeting HDAC4 and HDAC7 had no discernible effect on cell morphology or proliferation.

Conclusions:

  • Class I HDACs, particularly HDAC1 and HDAC3, play essential roles in regulating cancer cell proliferation and survival.
  • These findings support the development of Class I selective HDAC inhibitors as a targeted cancer therapeutic strategy.

More Related Videos

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique09:14

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique

Published on: January 14, 2016

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS09:20

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS

Published on: August 10, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...